Latest Insider Transactions at Salarius Pharmaceuticals, Inc. (SLRX)
This section provides a real-time view of insider transactions for Salarius Pharmaceuticals, Inc. (SLRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Salarius Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Salarius Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2023
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
6,432
+22.74%
|
-
|
|
Feb 13
2023
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,300
+22.95%
|
-
|
|
Jan 03
2023
|
Jonathan I Lieber Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+32.88%
|
-
|
|
Jan 03
2023
|
Paul Lammers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+45.6%
|
-
|
|
Jan 03
2023
|
Arnold C Hanish Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+50.0%
|
-
|
|
Jan 03
2023
|
Bruce J Mc Creedy Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+44.61%
|
-
|
|
Jan 03
2023
|
William K. Mc Vicar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+44.61%
|
-
|
|
Jan 03
2023
|
Tess Burleson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+34.6%
|
-
|
|
Jan 03
2023
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+37.23%
|
-
|
|
Jan 03
2023
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+34.16%
|
-
|
|
Nov 03
2022
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,314
+4.49%
|
$7,314
$1.73 P/Share
|
|
Nov 03
2022
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+3.38%
|
$10,000
$1.73 P/Share
|
|
Jun 07
2022
|
Jonathan I Lieber Director |
BUY
Open market or private purchase
|
Direct |
37,500
+50.0%
|
$0
$0.19 P/Share
|
|
Jun 07
2022
|
Tess Burleson Director |
BUY
Open market or private purchase
|
Direct |
27,700
+46.36%
|
$0
$0.18 P/Share
|
|
Jun 06
2022
|
William K. Mc Vicar Director |
BUY
Open market or private purchase
|
Indirect |
26,553
+50.0%
|
$0
$0.19 P/Share
|
|
Jun 03
2022
|
Arnold C Hanish Director |
BUY
Open market or private purchase
|
Indirect |
28,000
+37.66%
|
$0
$0.18 P/Share
|
|
May 31
2022
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Open market or private purchase
|
Direct |
28,000
+15.88%
|
$0
$0.18 P/Share
|
|
May 26
2022
|
David J. Arthur Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
21,900
+2.37%
|
$0
$0.18 P/Share
|
|
May 26
2022
|
David J. Arthur Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
22,000
+3.74%
|
$0
$0.18 P/Share
|
|
May 03
2022
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.67%
|
$0
$0.19 P/Share
|
|
May 03
2022
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+3.71%
|
$0
$0.19 P/Share
|
|
Mar 03
2022
|
David J. Arthur Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
139,488
+35.84%
|
$0
$0.39 P/Share
|
|
Mar 03
2022
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Open market or private purchase
|
Direct |
76,246
+40.87%
|
$0
$0.39 P/Share
|
|
Nov 03
2021
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,787
+18.6%
|
$0
$0.72 P/Share
|
|
Nov 03
2021
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,939
+6.72%
|
$0
$0.72 P/Share
|
|
Aug 17
2021
|
David J. Arthur Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
4,000
+1.94%
|
$0
$0.9 P/Share
|
|
Aug 10
2021
|
Arnold C Hanish Director |
BUY
Open market or private purchase
|
Indirect |
7,000
+27.61%
|
$0
$0.88 P/Share
|
|
May 03
2021
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,822
+9.26%
|
$0
$0.57 P/Share
|
|
May 03
2021
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
9,563
+26.68%
|
$0
$0.57 P/Share
|
|
Nov 03
2020
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,723
+22.02%
|
$0
$0.56 P/Share
|
|
Nov 03
2020
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,879
+5.34%
|
$0
$0.56 P/Share
|